Contact us

ESH Video

#ESHIMMUNE2024: EXTENDED DEADLINE FOR ABSTRACT SUBMISSION!

3^rd Translational Research Conference

IMMUNE & CELLULAR THERAPIES:

Focus on Advanced Gene-Engineered Immune Cells

September 13-15, 2024

Malahide (Dublin), Ireland

#ESHIMMUNE2024

EXTENDED DEADLINE FOR ABSTRACTS:
JULY 15^th!

Don't miss the opportunity to be selected
among the 5 best abstracts!*

Abstracts are eligible for an oral or a poster presentation.

*Selected Best abstract will receive complementary conference registration
and a chance to be part of the Best Abstract session!

CONFERENCE'S MAIN SCIENTIFIC TOPICS
• Clinical development of CAR-T cell therapy
• Emerging targets for cell therapy
• Receptor engineering for tumor therapy
• Gene editing to enhance efficacy
• Novel cell types and sources – beyond autologous
• Engineering immune cells in vivo
• Correlative analyses of response and resistance
• Overcoming barriers to improve response
• The future of engineered cell therapy

About the Conference:

The ESH 3^rd TRANSLATIONAL RESEARCH CONFERENCE: IMMUNE & CELLULAR THERAPIES proposes a programme of leading-edge basic and clinical science, as well as opportunities for informal scientific interaction with a panel of global experts in the field.

It is open to an international audience of biologists and clinicians, including those still in-training. This translational research conference will bring together biologists and clinicians with an interest in immune & cellular therapies with a focus on advanced gene-engineered immune cells.
New data will be presented and spirited debates on how to best to apply these insights to the future of immune & cellular therapies are expected.

CLICK HERE TO READ THE PRELIMINARY SCIENTIFIC PROGRAMME

MORE INFORMATION